stoxline Quote Chart Rank Option Currency Glossary
  
Cosmos Health Inc. (COSM)
1.17  -0.11 (-8.59%)    07-26 16:00
Open: 1.27
High: 1.29
Volume: 255,638
  
Pre. Close: 1.28
Low: 1.1495
Market Cap: 20(M)
Technical analysis
2024-07-26 4:43:20 PM
Short term     
Mid term     
Targets 6-month :  1.79 1-year :  2.1
Resists First :  1.53 Second :  1.79
Pivot price 1.26
Supports First :  0.97 Second :  0.62
MAs MA(5) :  1.19 MA(20) :  1.2
MA(100) :  0.78 MA(250) :  1.01
MACD MACD :  0.1 Signal :  0.1
%K %D K(14,3) :  47.2 D(3) :  48
RSI RSI(14): 54
52-week High :  2.04 Low :  0.46
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ COSM ] has closed above bottom band by 24.7%. Bollinger Bands are 35.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.29 - 1.3 1.3 - 1.3
Low: 1.14 - 1.14 1.14 - 1.15
Close: 1.16 - 1.17 1.17 - 1.18
Company Description

Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Headline News

Thu, 25 Jul 2024
Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland - StockTitan

Thu, 25 Jul 2024
Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar - StockTitan

Thu, 25 Jul 2024
Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar - AccessWire

Wed, 24 Jul 2024
Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity - StockTitan

Thu, 18 Jul 2024
Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units - StockTitan

Thu, 18 Jul 2024
Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule - StockTitan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 17 (M)
Shares Float 12 (M)
Held by Insiders 13 (%)
Held by Institutions 3.5 (%)
Shares Short 761 (K)
Shares Short P.Month 371 (K)
Stock Financials
EPS -4.24
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.4
Profit Margin -31.5 %
Operating Margin -23.6 %
Return on Assets (ttm) -16.6 %
Return on Equity (ttm) -62.8 %
Qtrly Rev. Growth 6.6 %
Gross Profit (p.s.) 0
Sales Per Share 2.94
EBITDA (p.s.) -0.92
Qtrly Earnings Growth 0 %
Operating Cash Flow -27 (M)
Levered Free Cash Flow -20 (M)
Stock Valuations
PE Ratio -0.28
PEG Ratio 0
Price to Book value 0.34
Price to Sales 0.39
Price to Cash Flow -0.74
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android